| 词条 | Cefpimizole |
| 释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444707809 | IUPAC_name = 2-[1-([(6R,7R)-2-carboxy-7-([(2R)-2-[(5-carboxy1H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl)pyridin-1-ium-4-yl]ethanesulfonate | image = Cefpimizole.png | width = 280 | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Rx-only | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 84880-03-5 | ATC_prefix = none | ATC_suffix = | ATC_supplemental = | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 2103902 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 24S58UHU7N | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D03427 | PubChem = 11765031 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 61863 | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C28H26N6O10S2/c35-23(18(16-4-2-1-3-5-16)31-24(36)19-20(27(38)39)30-14-29-19)32-21-25(37)34-22(28(40)41)17(13-45-26(21)34)12-33-9-6-15(7-10-33)8-11-46(42,43)44/h1-7,9-10,14,18,21,26H,8,11-13H2,(H5-,29,30,31,32,35,36,38,39,40,41,42,43,44)/t18-,21-,26-/m1/s1 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = LNZMRLHZGOBKAN-KAWPREARSA-N | chemical_formula = | C=28 | H=26 | N=6 | O=10 | S=2 | molecular_weight = 670.67 g/mol | smiles = C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)C4=C(N=CN4)C(=O)O)C(=O)[O-])C[N+]5=CC=C(C=C5)CCS(=O)(=O)O }} Cefpimizole (INN) is a third-generation cephalosporin antibiotic. References
4 : Cephalosporin antibiotics|Enantiopure drugs|Imidazoles|Pyridines |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。